{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:17:30Z","timestamp":1794003450374,"version":"4.8.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006390","name":"Universit\u00e9 de Lausanne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Creatine (Cr) is an organic acid essential for recycling ATP, important in tissues with high energy demand such as muscle or brain. Cr is synthesized in a 2-step pathway by the enzymes AGAT and GAMT, and transported by SLC6A8 (also called CrT). Cerebral Cr deficiency syndromes (CCDS), due to AGAT, GAMT or CrT deficiencies, are metabolic diseases characterized by brain Cr deficiency, causing a range of clinical features such as severe neurodevelopmental delays and intellectual disability, behavioral disturbances, motor dysfunction and epilepsy. Among CCDS, the X-linked CrT deficiency (CTD) is the most prevalent with no efficient treatment so far. Increasing number of human and animal studies contributes to the understanding of CTD pathology, its diagnosis and treatment, and the roles of Cr and CrT. However, most of them are focused in males and little is known about female carriers and how CrT deficiency affect them. In order to increase knowledge in female sex and roughly explore the relationship with SLC6A8 gene dosage, we present the first characterization of females' <jats:italic>Slc6a8<\/jats:italic><jats:sup><jats:italic>Y<\/jats:italic>389<jats:italic>C<\/jats:italic><\/jats:sup> rat model of CTD using both heterozygous and homozygous females. Brain Cr deficiency was found in all homozygous females, while heterozygous ones showed broad variability in brain Cr levels. Elevated and slightly elevated urinary Cr\/Crn ratio were present in homozygous and heterozygous females, respectively. Reduced body weight, muscular mass and locomotor activity were hallmarks of homozygous, but not heterozygous, females. However, in contrast to <jats:italic>Slc6a8<\/jats:italic><jats:sup><jats:italic>Y<\/jats:italic>389<jats:italic>C<\/jats:italic><\/jats:sup> KI males, spontaneous alternation and grooming behaviors were not affected in any type of <jats:italic>Slc6a8<\/jats:italic><jats:sup><jats:italic>Y<\/jats:italic>389<jats:italic>C<\/jats:italic><\/jats:sup> mutant female rats. Interestingly, both <jats:italic>Slc6a8<\/jats:italic><jats:sup><jats:italic>Y<\/jats:italic>389<jats:italic>C<\/jats:italic><\/jats:sup> mutant female rats exhibited behavioral abnormalities such as increased prevalence of altered behavioral response to handling, being more frequent in homozygous female rats. Moreover, heterozygous females presented increased anxiety-like behavior to novelty in Open Field Novel Object test and altered behavioral response with increased locomotor activity in response to light as stressor in the Light Dark Box test. These results are coherent with the limited data from CTD human female carriers, validating the <jats:italic>Slc6a8<\/jats:italic><jats:sup><jats:italic>Y<\/jats:italic>389<jats:italic>C<\/jats:italic><\/jats:sup> rat females as a promising tool to better understand CTD in female sex. They also provide new insights about CTD pathology, revealing sex and zygotic phenotypic differences, highlighting the importance of including females in the study of CTD.<\/jats:p>","DOI":"10.3389\/fnins.2025.1520550","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T10:15:09Z","timestamp":1745921709000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Heterozygous females from a rat model for creatine transporter deficiency reveal altered behavioral response to stressors, normal body weight and slight metabolic changes"],"prefix":"10.3389","volume":"19","author":[{"given":"Lara","family":"Duran-Trio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lanzillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunja","family":"Simicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clothilde","family":"Roux-Petronelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Sandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cudalbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Braissant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.12688\/f1000research.5369.1","article-title":"A novel mouse model of creatine transporter deficiency","volume":"3","author":"Baroncelli","year":"2014","journal-title":"F1000Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.nbd.2009.10.022","article-title":"Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes","volume":"37","author":"Braissant","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"RP88459","DOI":"10.7554\/eLife.88459","article-title":"Deciphering neuronal deficit and protein profile changes in human brain organoids from patients with creatine transporter deficiency","volume":"12","author":"Broca-Brisson","year":"2023","journal-title":"Elife"},{"key":"B4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s11011-018-0197-3","article-title":"Treatment outcome of creatine transporter deficiency: international retrospective cohort study","volume":"33","author":"Bruun","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/0192623315570339","article-title":"Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears","volume":"43","author":"Cora","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"106720","DOI":"10.1016\/j.nbd.2024.106720","article-title":"Impaired brain glucose metabolism as a biomarker for evaluation of dodecyl creatine ester in creatine transporter deficiency: insights from patient brain-derived organoids and in vivo [18F]FDG PET imaging in a mouse model","volume":"202","author":"Disdier","year":"2024","journal-title":"Neurobiol. Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jimd.12470","article-title":"Creatine transporter-deficient rat model shows motor dysfunction, cerebellar alterations, and muscle creatine deficiency without muscle atrophy","volume":"45","author":"Duran-Trio","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41598-020-80824-x","article-title":"A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism","volume":"11","author":"Duran-Trio","year":"2021","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ymgme.2021.12.005","article-title":"Current and potential new treatment strategies for creatine deficiency syndromes","volume":"135","author":"Fernandes-Pires","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/cells11030535","article-title":"Mechanisms of choice in X-chromosome inactivation","volume":"11","author":"Furlan","year":"2022","journal-title":"Cells"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/genes12081123","article-title":"The role of preclinical models in creatine transporter deficiency: neurobiological mechanisms, biomarkers and therapeutic development","volume":"12","author":"Ghirardini","year":"2021","journal-title":"Genes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00726-016-2189-0","article-title":"Creatine synthesis and exchanges between brain cells: what can be learned from human creatine deficiencies and various experimental models?","volume":"48","author":"Hanna-El-Daher","year":"2016","journal-title":"Amino acids"},{"key":"B13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10545-013-9619-x","article-title":"Female mice heterozygous for creatine transporter deficiency show moderate cognitive deficits","volume":"37","author":"Hautman","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1086\/323765","article-title":"Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans","volume":"69","author":"Item","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1101\/gr.249706.119","article-title":"Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming","volume":"29","author":"Janiszewski","year":"2019","journal-title":"Genome Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jpeds.2018.11.008","article-title":"Early indicators of creatine transporter deficiency","volume":"206","author":"Miller","year":"2019","journal-title":"J. Ped"},{"key":"B18","doi-asserted-by":"publisher","first-page":"107694","DOI":"10.1016\/j.ymgme.2023.107694","article-title":"X-linked creatine transporter (SLC6A8) deficiency in females: difficult to recognize, but a potentially treatable disease","volume":"140","author":"Nielsen","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"dev183095","DOI":"10.1242\/dev.183095","article-title":"\u00d7 chromosome inactivation in human development","volume":"147","author":"Patrat","year":"2020","journal-title":"Development"},{"key":"B20","unstructured":"Pinheiro\n              J.\n            \n            \n              Bates\n              D.\n            \n            \n              DebRoy\n              S.\n            \n            \n              Sarkar\n              D.\n            \n          \n          nlme: Linear and Nonlinear Mixed Effects Models.\n          \n          2015"},{"key":"B21","unstructured":"R: A Language and Environment for Statistical Computing.\n          \n          2018"},{"key":"B22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1086\/422102","article-title":"High prevalence of SLC6A8 deficiency in X-linked mental retardation","volume":"75","author":"Rosenberg","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1086\/320595","article-title":"X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome","volume":"68","author":"Salomons","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"B24","first-page":"181","article-title":"\u201cCreatine deficiency syndromes,\u201d","volume-title":"Pediatric Endocrinology and Inborn Errors of Metabolism (2nd Edn.)","author":"Schulze","year":"2017"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s00726-015-2161-4","article-title":"New insights into the trophic and cytoprotective effects of creatine in in vitro and in vivo models of cell maturation","volume":"48","author":"Sestili","year":"2016","journal-title":"Amino Acids"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e16187","DOI":"10.1371\/journal.pone.0016187","article-title":"Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency","volume":"6","author":"Skelton","year":"2011","journal-title":"PLoS ONE"},{"key":"B27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3389\/fphys.2018.00773","article-title":"A mouse model of creatine transporter deficiency reveals impaired motor function and muscle energy metabolism","volume":"9","author":"Stockebrand","year":"2018","journal-title":"Front. Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1203\/00006450-199409000-00023","article-title":"Creatine deficiency in the brain: a new, treatable inborn error of metabolism","volume":"36","author":"St\u00f6ckler","year":"1994","journal-title":"Pediatr. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1055\/s-0034-1386772","article-title":"Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders","volume":"34","author":"St\u00f6ckler-Ipsiroglu","year":"2014","journal-title":"Semin. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/jmedgenet-2013-101658","article-title":"Phenotype and genotype in 101 males with X-linked creatine transporter deficiency","volume":"50","author":"van de Kamp","year":"2013","journal-title":"J. Med. Genet."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4_9","article-title":"\u201cData analysis,\u201d","volume-title":"ggplot2. Use R!","author":"Wickham","year":"2016"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol. Rev."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1520550\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T10:15:13Z","timestamp":1745921713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1520550\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":32,"alternative-id":["10.3389\/fnins.2025.1520550"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1520550","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"article-number":"1520550"}}